<p>ICU Medical, Inc. (纳斯达克股票代码:ICUI) 在九月份看到了空头头寸大幅下降。截至 9 月 15 日，空头头寸总计为 831,100 股，较 8 月 31 日的 924,500 股下降了 10.1%。目前，公司股份中有 3.7% 被空头卖空。根据平均每日交易量为 337,000 股，目前的天数覆盖率为 2.5 天。</p>
<h2>华尔街分析师预测增长</h2>
<p>多位研究分析师对 ICUI 股票发表了看法。Needham &amp; Company LLC 在 8 月 8 日星期四的研究报告中重申了对 ICU Medical 股票的&#34;持有&#34;评级。KeyCorp 将 ICU Medical 的目标股价从 136.00 美元上调至 147.00 美元，并在 8 月 8 日星期四的研究报告中给予公司&#34;超重&#34;评级。Raymond James 将 ICU Medical 的目标股价从 158.00 美元上调至 190.00 美元，并在 9 月 12 日星期四的研究报告中给予公司&#34;表现优异&#34;评级。最后，StockNews.com 在 9 月 12 日星期四的研究报告中将 ICU Medical 股票的评级从&#34;持有&#34;上调至&#34;买入&#34;。一位投资分析师对该股票给予持有评级，四位分析师给予公司股票买入评级。根据 MarketBeat.com 的数据，ICU Medical 的共识评级为&#34;中等买入&#34;，平均目标股价为 149.00 美元。</p>
<p><strong>阅读我们关于 ICUI 的最新股票报告</strong></p>
<h2>ICU Medical 内部交易</h2>
<p>另外，副总裁 Daniel Woolson 于 8 月 30 日星期五进行了一笔交易，卖出了 ICU Medical 股票的 2,502 股。这些股票的平均价格为 163.22 美元，交易总额为 408,376.44 美元。交易完成后，该副总裁现在持有公司的 13,107 股股份，价值约 2,139,324.54 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，可以通过此链接访问。此外，副总裁 Daniel Woolson 于 8 月 30 日星期五进行了一笔交易，卖出了公司股票的 2,502 股。这些股票的平均价格为 163.22 美元，交易总额为 408,376.44 美元。交易完成后，该副总裁现在持有公司的 13,107 股股份，价值 2,139,324.54 美元。该交易已在提交给 SEC 的文件中披露，可以通过 SEC 网站访问。此外，副总裁 Virginia Ruth Sanzone 于 8 月 8 日星期四进行了一笔交易，卖出了公司股票的 2,050 股。这些股票的平均价格为 144.11 美元，交易总额为 295,425.50 美元。交易完成后，该副总裁现在持有公司的 4,482 股股份，价值约 645,901.02 美元。此次交易的披露可以在此处找到。内部人士在上一季度共出售了价值 4,537,802 美元的公司股票总计 28,552 股。公司股份的 6.70% 归内部人士所有。</p>
<h2>对 ICU Medical 的对冲基金看法</h2>
<p>机构投资者和对冲基金最近调整了他们对该股票的持股。Scout Investments Inc.在第一季度将其对 ICU Medical 的持股增加了 16.3%。Scout Investments Inc.现在拥有 51,819 股 ICU Medical 的股份，价值 5,463,000 美元，比上一季度增加了 7,272 股。Wakefield Asset Management LLLP 在第一季度收购了 ICU Medical 的新头寸，价值 989,000 美元。Vanguard Group Inc.在第四季度将其对 ICU Medical 的持股增加了 14.8%。Vanguard Group Inc.现在拥有 2,440,729 股 ICU Medical 的股份，价值 243,438,000 美元，比上一季度增加了 315,103 股。SG Americas Securities LLC 在第二季度将其对 ICU Medical 的持股增加了 441.7%。SG Americas Securities LLC 现在拥有 5,818 股 ICU Medical 的股份，价值 691,000 美元，比上一季度增加了 4,744 股。最后，Sei Investments Co.在第一季度将其对 ICU Medical 的持股增加了 52.1%。Sei Investments Co.现在拥有 28,586 股 ICU Medical 的股份，价值 3,068,000 美元，比上一季度增加了 9,793 股。目前，该股票的 96.10% 由机构投资者和对冲基金持有。</p>
<h2>ICU Medical 股价下跌 0.0%</h2>
<p>ICUI 股票在周五交易中下跌 0.01 美元，收于 174.47 美元。公司股票的交易量为 177,791 股，相比平均交易量 280,425 股有所下降。该公司的五十日移动平均股价为 154.77 美元，两百日移动平均股价为 124.01 美元。公司的速动比率为 1.08，流动比率为 2.41，负债权益比为 0.76。该公司的市值为 42.5 亿美元，市盈率为-71.21，贝塔系数为 0.65。ICU Medical 的一年最低股价为 78.28 美元，最高股价为 181.87 美元。</p>
<p>ICU Medical (纳斯达克股票代码:ICUI) 在 8 月 7 日星期三发布了其最新的财报。这家医疗器械供应商报告称，该季度每股收益为 1.56 美元，超过分析师预期的 1.00 美元 0.56 美元。该季度营收为 5.965 亿美元，超过市场预期的 5.5664 亿美元。ICU Medical 的净利润率为-3.07%，股东权益回报率为 5.01%。公司当季营收同比增长了 8.6%。在去年同期，公司每股收益为 1.58 美元。分析师预计 ICU Medical 今年将实现每股盈利 3.76 美元。</p>
<h2>关于 ICU Medical（获取免费报告）</h2>
<p>ICU 医疗公司及其子公司在全球范围内开发、制造和销售用于输液治疗、血管通路和重要护理应用的医疗器械。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅装置；ChemoClave 和 ChemoLock 封闭系统转移装置，用于限制有害药物或蒸气浓度的泄漏，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 用于门静脉通路的非穿刺针；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
<h2>阅读更多</h2>
<ul>
<li>我们喜欢的五只股票胜过 ICU 医疗</li>
<li>选举股票：选举如何影响股市</li>
<li>西蒙地产房地产投资信托：增长和稳定股息的安全选择</li>
<li>如何确定要购买哪种加密货币：投资者指南</li>
<li>CarMax 令人印象深刻的涨势：投资者应该关注什么</li>
<li>哪些华尔街分析师最准确？</li>
<li>MarketBeat 周评 – 9/23 - 9/27</li>
</ul>
<p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队的审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<p>→ 注意：您有时间直到 11 月 19 日星期二（来自市场幕后）（广告）</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw"/></p>
<h2>您现在是否应该投资 1,000 美元购买 ICU 医疗股票？</h2>
<p>在考虑购买 ICU 医疗股票之前，您应该听听这个。</p>
<p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉客户现在购买的股票清单... 而 ICU 医疗并不在其中。</p>
<p>尽管 ICU 医疗目前在分析师中具有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ICU医疗

<p>ICU 医疗（NASDAQ:ICUI）在九月份空头头寸下降了 10.1%，截至 9 月 15 日，空头售出了 831,100 股股票。这一数字较 8 月底的 924,500 股有所下降。目前的空头头寸比率为 2.5 天，占公司股份的 3.7%。分析师对该股票的评级褒贬不一，其中一家持有评级，四家持有买入评级，共识评级为 “中等买入”。内部人士在上个季度共售出了 28,552 股股票，而机构投资者持有该股票的比例为 96.10%</p>

<p>ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) saw a large decline in short interest in the month of September. As of September 15th, there was short interest totalling 831,100 shares, a decline of 10.1% from the August 31st total of 924,500 shares. Currently, 3.7% of the company's shares are short sold. Based on an average daily trading volume, of 337,000 shares, the days-to-cover ratio is currently 2.5 days.</p>
<div class="lb-trans"><p>ICU Medical, Inc. (纳斯达克股票代码:ICUI) 在九月份看到了空头头寸大幅下降。截至 9 月 15 日，空头头寸总计为 831,100 股，较 8 月 31 日的 924,500 股下降了 10.1%。目前，公司股份中有 3.7% 被空头卖空。根据平均每日交易量为 337,000 股，目前的天数覆盖率为 2.5 天。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>A number of research analysts have weighed in on ICUI shares. Needham &amp; Company LLC reaffirmed a &#34;hold&#34; rating on shares of ICU Medical in a research note on Thursday, August 8th. KeyCorp lifted their price target on shares of ICU Medical from $136.00 to $147.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, August 8th. Raymond James lifted their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, September 12th. Finally, StockNews.com raised shares of ICU Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research note on Thursday, September 12th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, ICU Medical has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $149.00.</p>
<div class="lb-trans"><p>多位研究分析师对 ICUI 股票发表了看法。Needham &amp; Company LLC 在 8 月 8 日星期四的研究报告中重申了对 ICU Medical 股票的&#34;持有&#34;评级。KeyCorp 将 ICU Medical 的目标股价从 136.00 美元上调至 147.00 美元，并在 8 月 8 日星期四的研究报告中给予公司&#34;超重&#34;评级。Raymond James 将 ICU Medical 的目标股价从 158.00 美元上调至 190.00 美元，并在 9 月 12 日星期四的研究报告中给予公司&#34;表现优异&#34;评级。最后，StockNews.com 在 9 月 12 日星期四的研究报告中将 ICU Medical 股票的评级从&#34;持有&#34;上调至&#34;买入&#34;。一位投资分析师对该股票给予持有评级，四位分析师给予公司股票买入评级。根据 MarketBeat.com 的数据，ICU Medical 的共识评级为&#34;中等买入&#34;，平均目标股价为 149.00 美元。</p>
</div><p><strong>Read Our Latest Stock Report on ICUI</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 ICUI 的最新股票报告</strong></p>
</div><h2>Insider Transactions at ICU Medical</h2>
<div class="lb-trans"><h2>ICU Medical 内部交易</h2>
</div><p>In other news, VP Daniel Woolson sold 2,502 shares of ICU Medical stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the sale, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, VP Daniel Woolson sold 2,502 shares of the business's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at $2,139,324.54. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the business's stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the transaction, the vice president now owns 4,482 shares of the company's stock, valued at approximately $645,901.02. The disclosure for this sale can be found here. Insiders sold a total of 28,552 shares of company stock worth $4,537,802 in the last quarter. 6.70% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>另外，副总裁 Daniel Woolson 于 8 月 30 日星期五进行了一笔交易，卖出了 ICU Medical 股票的 2,502 股。这些股票的平均价格为 163.22 美元，交易总额为 408,376.44 美元。交易完成后，该副总裁现在持有公司的 13,107 股股份，价值约 2,139,324.54 美元。该交易已在提交给美国证券交易委员会（SEC）的文件中披露，可以通过此链接访问。此外，副总裁 Daniel Woolson 于 8 月 30 日星期五进行了一笔交易，卖出了公司股票的 2,502 股。这些股票的平均价格为 163.22 美元，交易总额为 408,376.44 美元。交易完成后，该副总裁现在持有公司的 13,107 股股份，价值 2,139,324.54 美元。该交易已在提交给 SEC 的文件中披露，可以通过 SEC 网站访问。此外，副总裁 Virginia Ruth Sanzone 于 8 月 8 日星期四进行了一笔交易，卖出了公司股票的 2,050 股。这些股票的平均价格为 144.11 美元，交易总额为 295,425.50 美元。交易完成后，该副总裁现在持有公司的 4,482 股股份，价值约 645,901.02 美元。此次交易的披露可以在此处找到。内部人士在上一季度共出售了价值 4,537,802 美元的公司股票总计 28,552 股。公司股份的 6.70% 归内部人士所有。</p>
</div><h2>Hedge Funds Weigh In On ICU Medical</h2>
<div class="lb-trans"><h2>对 ICU Medical 的对冲基金看法</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. Scout Investments Inc. increased its holdings in shares of ICU Medical by 16.3% in the first quarter. Scout Investments Inc. now owns 51,819 shares of the medical instruments supplier's stock valued at $5,463,000 after purchasing an additional 7,272 shares during the last quarter. Wakefield Asset Management LLLP acquired a new position in shares of ICU Medical in the first quarter valued at $989,000. Vanguard Group Inc. increased its holdings in shares of ICU Medical by 14.8% in the fourth quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier's stock valued at $243,438,000 after purchasing an additional 315,103 shares during the last quarter. SG Americas Securities LLC increased its holdings in shares of ICU Medical by 441.7% in the second quarter. SG Americas Securities LLC now owns 5,818 shares of the medical instruments supplier's stock valued at $691,000 after purchasing an additional 4,744 shares during the last quarter. Finally, Sei Investments Co. increased its holdings in shares of ICU Medical by 52.1% in the first quarter. Sei Investments Co. now owns 28,586 shares of the medical instruments supplier's stock valued at $3,068,000 after purchasing an additional 9,793 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近调整了他们对该股票的持股。Scout Investments Inc.在第一季度将其对 ICU Medical 的持股增加了 16.3%。Scout Investments Inc.现在拥有 51,819 股 ICU Medical 的股份，价值 5,463,000 美元，比上一季度增加了 7,272 股。Wakefield Asset Management LLLP 在第一季度收购了 ICU Medical 的新头寸，价值 989,000 美元。Vanguard Group Inc.在第四季度将其对 ICU Medical 的持股增加了 14.8%。Vanguard Group Inc.现在拥有 2,440,729 股 ICU Medical 的股份，价值 243,438,000 美元，比上一季度增加了 315,103 股。SG Americas Securities LLC 在第二季度将其对 ICU Medical 的持股增加了 441.7%。SG Americas Securities LLC 现在拥有 5,818 股 ICU Medical 的股份，价值 691,000 美元，比上一季度增加了 4,744 股。最后，Sei Investments Co.在第一季度将其对 ICU Medical 的持股增加了 52.1%。Sei Investments Co.现在拥有 28,586 股 ICU Medical 的股份，价值 3,068,000 美元，比上一季度增加了 9,793 股。目前，该股票的 96.10% 由机构投资者和对冲基金持有。</p>
</div><h2>ICU Medical Stock Down 0.0 %</h2>
<div class="lb-trans"><h2>ICU Medical 股价下跌 0.0%</h2>
</div><p>Shares of ICUI stock traded down $0.01 during trading on Friday, reaching $174.47. The company's stock had a trading volume of 177,791 shares, compared to its average volume of 280,425. The business has a fifty day moving average price of $154.77 and a 200-day moving average price of $124.01. The company has a quick ratio of 1.08, a current ratio of 2.41 and a debt-to-equity ratio of 0.76. The company has a market cap of $4.25 billion, a price-to-earnings ratio of -71.21 and a beta of 0.65. ICU Medical has a one year low of $78.28 and a one year high of $181.87.</p>
<div class="lb-trans"><p>ICUI 股票在周五交易中下跌 0.01 美元，收于 174.47 美元。公司股票的交易量为 177,791 股，相比平均交易量 280,425 股有所下降。该公司的五十日移动平均股价为 154.77 美元，两百日移动平均股价为 124.01 美元。公司的速动比率为 1.08，流动比率为 2.41，负债权益比为 0.76。该公司的市值为 42.5 亿美元，市盈率为-71.21，贝塔系数为 0.65。ICU Medical 的一年最低股价为 78.28 美元，最高股价为 181.87 美元。</p>
</div><p>ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.00 by $0.56. The business had revenue of $596.50 million for the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. Analysts anticipate that ICU Medical will post 3.76 earnings per share for the current year.</p>
<div class="lb-trans"><p>ICU Medical (纳斯达克股票代码:ICUI) 在 8 月 7 日星期三发布了其最新的财报。这家医疗器械供应商报告称，该季度每股收益为 1.56 美元，超过分析师预期的 1.00 美元 0.56 美元。该季度营收为 5.965 亿美元，超过市场预期的 5.5664 亿美元。ICU Medical 的净利润率为-3.07%，股东权益回报率为 5.01%。公司当季营收同比增长了 8.6%。在去年同期，公司每股收益为 1.58 美元。分析师预计 ICU Medical 今年将实现每股盈利 3.76 美元。</p>
</div><h2>About ICU Medical (Get Free Report)</h2>
<div class="lb-trans"><h2>关于 ICU Medical（获取免费报告）</h2>
</div><p>ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.</p>
<div class="lb-trans"><p>ICU 医疗公司及其子公司在全球范围内开发、制造和销售用于输液治疗、血管通路和重要护理应用的医疗器械。其输液治疗产品包括 MicroClave、MicroClave Clear 和 NanoClave 品牌的无针产品；Neutron 导管通畅装置；ChemoClave 和 ChemoLock 封闭系统转移装置，用于限制有害药物或蒸气浓度的泄漏，阻止环境污染物进入系统，并消除针刺伤害的风险；Tego 无针连接器；Deltec GRIPPER 用于门静脉通路的非穿刺针；以及 ClearGuard、SwabCap 和 SwabTip 消毒帽。</p>
</div><h2>Read More</h2>
<ul>
<li>Five stocks we like better than ICU Medical</li>
<li>Election Stocks: How Elections Affect the Stock Market</li>
<li>Simon Property REIT: A Safe Bet for Growth and Steady Dividends</li>
<li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li>
<li>CarMax’s Impressive Rally: What Investors Should Watch Next</li>
<li>Which Wall Street Analysts are the Most Accurate?</li>
<li>MarketBeat Week in Review – 9/23 - 9/27</li>
</ul>
<div class="lb-trans"><h2>阅读更多</h2>
<ul>
<li>我们喜欢的五只股票胜过 ICU 医疗</li>
<li>选举股票：选举如何影响股市</li>
<li>西蒙地产房地产投资信托：增长和稳定股息的安全选择</li>
<li>如何确定要购买哪种加密货币：投资者指南</li>
<li>CarMax 令人印象深刻的涨势：投资者应该关注什么</li>
<li>哪些华尔街分析师最准确？</li>
<li>MarketBeat 周评 – 9/23 - 9/27</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>这则即时新闻警报是由叙事科技和 MarketBeat 的金融数据生成，旨在为读者提供最快速和最准确的报道。本故事在发布前经过 MarketBeat 编辑团队的审核。请将有关本故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><p>→ NOTICE: You have until Tuesday, November 19th (From Behind the Markets)(Ad)</p>
<div class="lb-trans"><p>→ 注意：您有时间直到 11 月 19 日星期二（来自市场幕后）（广告）</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Nzgw" alt="" original-src="https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9780&amp;Placement=NativeDisplay&amp;Source=NativeDisplay"/></p>
<h2>Should you invest $1,000 in ICU Medical right now?</h2>
<div class="lb-trans"><h2>您现在是否应该投资 1,000 美元购买 ICU 医疗股票？</h2>
</div><p>Before you consider ICU Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑购买 ICU 医疗股票之前，您应该听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 追踪华尔街评级最高且表现最佳的研究分析师以及他们每天向客户推荐的股票。MarketBeat 已确定了五只顶级分析师悄悄告诉客户现在购买的股票清单... 而 ICU 医疗并不在其中。</p>
</div><p>While ICU Medical currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 ICU 医疗目前在分析师中具有 “中等买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

ICU 医疗公司（纳斯达克代码：ICUI）的空头头寸下降了 10.1%